Deep Brain Stimulation (DBS) is an advanced neurosurgical therapy that uses controlled electrical signals to manage Parkinson ...

Encora's device is set to be available in the US via a prescription-only model.

Scientists discovered a brain network behind Parkinson's symptoms, leading to 2.5x better treatment results when targeted ...

A Henry Ford Health neurosurgeon said that in the vast majority of cases, the procedure causes 70% to 90% improvement in a ...

For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. | For millions of Americans with essential tremor, ...

Parkinson's Disease is a movement disorder that affects the nervous system. Deep Brain Stimulation surgery, or DBS, is helping those living with the condition.

A multi-institutional team of researchers led by Virginia Tech's Fralin Biomedical Research Institute at VTC has for the first time identified specific patterns of brain chemical activity that predict ...

A new international study points to a specific brain network as the core driver of Parkinson’s disease. Scientists found that ...

A new federal pilot program is changing how some seniors access healthcare under traditional Medicare. As of January 1, 2026, ...

Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even thinking. That may be because the disease disrupts communication in a brain ...

Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. “We started ...

Encora Therapeutics announced today that it has received FDA 510(k) clearance for its Encora X1 wrist-worn device.